360b / Shutterstock.com
The Supreme Court of California has ruled that so-called “pay-for-delay” patent settlements can be challenged under state antitrust law in a case centering on Bayer’s antibiotic drug Cipro (ciprofloxacin).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Supreme Court of California, antitrust, pay-for-delay, Bayer, Barr, Cipro